skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Metástase Neoplásica remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer
Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of neoadjuvant chemotherapy on low-density lipoprotein (LDL) receptor and LDL receptor-related protein 1 (LRP-1) receptor in locally advanced breast cancer

L. A. Pires R Hegg; E. R Freitas; E. R Tavares; C. P Almeida; E. C Baracat; Raul Cavalcante Maranhão

Brazilian Journal of Medical and Biological Research Ribeirão Preto v. 45, n. 6, p. 557-564, 2012

Ribeirão Preto 2012

Localização: FM - Fac. Medicina    (BCSEP 007 2012 )(Acessar)

2
One hour infusion of clodronate disodium for treating oncological pain due to bone metastases of solid tumors among adults
One hour infusion of clodronate disodium for treating oncological pain due to bone metastases of solid tumors among adults
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

One hour infusion of clodronate disodium for treating oncological pain due to bone metastases of solid tumors among adults

Silvia Regina Graziani Silvana Maria Graziani; Nádia Aparecida Bossa; Roberto Hegg; Raul Cavalcante Maranhão; International Meeting on Cancer Induced Bone Disease (7. 2008 Edinburgh)

Cancer Treatment Reviews New York v. 34, suppl. 1, p. S83-S84 res. P75, 2008

New York 2008

Localização: FM - Fac. Medicina    (BCSEP 444 2008 )(Acessar)

3
Adjuvant denosumab in early breast cancer (D-CARE) an international, multicentre, randomised, controlled, phase 3 trial
Adjuvant denosumab in early breast cancer (D-CARE) an international, multicentre, randomised, controlled, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant denosumab in early breast cancer (D-CARE) an international, multicentre, randomised, controlled, phase 3 trial

Robert Coleman Dianne M Finkelstein; Carlos Barrios; Miguel Martin; Hiroji Iwata; Roberto Hegg; John Glaspy; Alvaro Montano Perianez; Katia Tonkin; Ines Deleu

Lancet oncology v. 21, n. 1, p. 60-72, 2020

New York 2020

Acesso online. A biblioteca também possui exemplares impressos.

4
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer

José Baselga Javier Cortés; Sung Bae Kim; Seock-Ah Im; Roberto Hegg; Young-Hyuck Im; Laslo Roman; José Luiz Pedrini; Tadeusz Pienkowski; Adam Knott; Emma Clark; Mark C Benyunes; Ggraham Ross; Sandra M Swain

The New England Journal of Medicine Boston v. 366, n. 2, p. 109-119, 2012

Boston 2012

Localização: FM - Fac. Medicina    (BCSEP 289 2012 )(Acessar)

5
First-line trastuzumab plus an aromatase inhibitor, with or without pertuzumab, in human epidermal growth factor Receptor 2-positive and hormone receptor-positive metastatic or locally advanced breast cancer (PERTAIN) a randomized, open-label phase II trial
First-line trastuzumab plus an aromatase inhibitor, with or without pertuzumab, in human epidermal growth factor Receptor 2-positive and hormone receptor-positive metastatic or locally advanced breast cancer (PERTAIN) a randomized, open-label phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

First-line trastuzumab plus an aromatase inhibitor, with or without pertuzumab, in human epidermal growth factor Receptor 2-positive and hormone receptor-positive metastatic or locally advanced breast cancer (PERTAIN) a randomized, open-label phase II trial

Mothaffar Rimawi Jean-Marc Ferrero; Juan de la Haba-rodriguez; Christopher Poole; Sabino De Placido; C. Kent Osborne; Roberto Hegg; Valerie Easton; Christine Wohlfarth; Grazia Arpino

Journal of clinical oncology v. 36, n. 28, p. 2826-2835, 2018

Alexandria 2018

Acesso online. A biblioteca também possui exemplares impressos.

6
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

T Bachelot E Ciruelos; A Schneeweiss; F Puglisi; T Peretz-Yablonski; I Bondarenko; S Paluch-shimon; A Wardley; J. -L Merot; Roberto Hegg

Annals of oncology v. 30, n. 5, p. 766-773, 2019

Oxford 2019

Acesso online. A biblioteca também possui exemplares impressos.

7
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer

José Baselga Javier Cortés; Sung Bae Kim; Seock-Ah Im; Roberto Hegg; Young-Hyuck Im; Laslo Roman; José Luiz Pedrini; Tadeusz Pienkowski; Adam Knott; Emma Clark; Mark C Benyunes; Ggraham Ross; Sandra M Swain

The New England Journal of Medicine Boston v. 366, n. 2, p. 109-119, 2012

Boston 2012

Localização: FM - Fac. Medicina    (BCSEP 289 2012 )(Acessar)

8
Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer
Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer

John R. Mackey Manuel Ramos-Vazquez Oleg Lipatov,; Nicole McCarthy; Dmitriy Krasnozhon; Vladimir Semiglazov; Alexey Manikhas; Karen A Gelmon; Gottfried E Konecny; Marc Webster; Roberto Hegg; Sunil Verma; Vera Gorbunova; Dany Abi Gerges; Francois Thireau; Helena Fung; Lorinda Simms; Marc Buyse; Ayman Ibrahim; Miguel Martin

Journal of Clinical Oncology New York v. 33, n. 2, p. 141-148, 2015

New York 2015

Acesso online. A biblioteca também possui exemplares impressos.

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (4)

Data de Publicação 

De até
Refinar
  1. Antes de2012  (1)
  2. 2012Até2014  (3)
  3. 2015Até2017  (1)
  4. 2018Até2019  (2)
  5. Após 2019  (1)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.